Bolt Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Bolt Biotherapeutics's estimated annual revenue is currently $15.7M per year.
- Bolt Biotherapeutics's estimated revenue per employee is $155,000
- Bolt Biotherapeutics's total funding is $198.5M.
- Bolt Biotherapeutics's current valuation is $144.7M. (January 2022)
Employee Data
- Bolt Biotherapeutics has 101 Employees.
- Bolt Biotherapeutics grew their employee count by 1% last year.
Bolt Biotherapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | VP Biometrics | Reveal Email/Phone |
4 | VP Clinical Development | Reveal Email/Phone |
5 | VP CMC and Quality | Reveal Email/Phone |
6 | VP, Head Regulatory Affairs | Reveal Email/Phone |
7 | VP, Head Biometrics | Reveal Email/Phone |
8 | VP Clinical Operations | Reveal Email/Phone |
9 | VP Finance | Reveal Email/Phone |
10 | VP Program Management | Reveal Email/Phone |
Bolt Biotherapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Bolt Biotherapeutics?
Bolt Biotherapeutics is a start-up with compelling technology from Dr. Engleman?s Lab at Stanford University, which demonstrated complete cures in numerous cancer models. The company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company?s future leaders to help it further develop and bring to patients novel and curative biotherapies.
keywords:N/A$198.5M
Total Funding
101
Number of Employees
$15.7M
Revenue (est)
1%
Employee Growth %
$144.7M
Valuation
N/A
Accelerator
Bolt Biotherapeutics News
In addition, Bolt Bio is developing new immuno-oncology Boltbody ISACs through strategic collaborations with leading biopharmaceutical companies...
About Bolt Biotherapeutics, Inc. Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company pioneering a new class of immuno-oncology...
Bolt Therapeutics files for $250M mixed shelf offering. Mar. 30, 2022 6:07 PM ETBolt Biotherapeutics, Inc. (BOLT)By: Jonathan Block, SA News Editor1 Comment.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $21M | 104 | -4% | N/A |
#2 | $21.4M | 105 | 14% | $51M |
#3 | $15.2M | 105 | 2% | $24.2M |
#4 | $18.7M | 107 | 10% | N/A |
#5 | $17.1M | 110 | -29% | $319M |